ID   UT-EC-2C
AC   CVCL_WM05
SY   University of Turku-Endometrial Carcinoma-2C
DR   IARC_TP53; 21690
DR   Wikidata; Q98134376
RX   PubMed=9887230;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
CC   Derived from site: Metastatic; Abdominal cavity; UBERON=UBERON_0003684.
DI   NCIt; C114656; Endometrial adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X004 ! UT-EC-2A
OI   CVCL_X005 ! UT-EC-2B
SX   Female
AG   45-46Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 7
//
RX   PubMed=9887230; DOI=10.1006/gyno.1998.5194;
RA   Rantanen V., Grenman S.E., Kurvinen K., Hietanen S.H., Raitanen M.,
RA   Syrjanen S.M.;
RT   "p53 mutations and presence of HPV DNA do not correlate with
RT   radiosensitivity of gynecological cancer cell lines.";
RL   Gynecol. Oncol. 71:352-358(1998).
//